| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $15.43B | -5.1% |
| Cost of Revenue | $8.99B | -8.0% |
| Gross Profit | $6.44B | -0.9% |
| R&D Expense | $805.2M | +21.6% |
| SG&A Expense | $4.65B | +11.3% |
| Operating Income | $766.2M | -52.6% |
| Interest Expense | $573.1M | -3.3% |
| Pre-tax Income | $202.9M | -92.8% |
| Income Tax | $148.2M |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $991.9M | -21.3% |
| Accounts Receivable | $3.70B | -3.0% |
| Inventory | $3.47B | -1.4% |
| Current Assets | $12.98B | +22.0% |
| Total Assets | $47.69B | -4.7% |
| Current Liabilities | $7.78B | +15.3% |
| Long-term Debt | $16.19B | -10.1% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $2.80B | -5.2% |
| Capital Expenditures | $377.0M | -7.1% |
| Investing Cash Flow | -$764.1M | -150.3% |
| Financing Cash Flow | -$2.30B | +40.6% |
| Free Cash Flow | $2.42B | -4.9% |
| -79.8% |
| Net Income | $54.7M | -97.4% |
| EPS (Basic) | $0.05 | -97.1% |
| EPS (Diluted) | $0.05 | -97.1% |
| Total Liabilities |
| $27.22B |
| -6.0% |
| Stockholders' Equity | $20.47B | -2.9% |